TURBO-BULL-CERTIFICATE - IPSEN | Real-time Euronext Paris 07:09:52 2024-05-29 am EDT | ||
| 1.305 EUR | +5.67% |
|
| Current month | +25.38% | ||
| 1 month | +32.09% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
Latest news about IPSEN
More news
| Date | Price | Change |
|---|---|---|
| 24-05-29 | 1.305 | +5.67% |
| 24-05-28 | 1.235 | -5.36% |
| 24-05-27 | 1.305 | -7.12% |
| 24-05-24 | 1.405 | -3.44% |
| 24-05-23 | 1.455 | +5.05% |
Real-time Euronext Paris
Last update May 29, 2024 at 07:09 am EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | 
Société Générale
|
| 9R81S | |
| ISIN | DE000SW72DL1 |
| Date issued | 2024-03-21 |
| Strike | 95 € |
| Maturity | 2024-06-21 (24 Days) |
| Parity | 20 : 1 |
| Emission price | 0.51 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.475 € |
|---|---|
| Lowest since issue | 0.545 € |
| Spread | 0.01 € |
| Spread % | 0.76% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
119.4
EUR
Average target price
126.4
EUR
Spread / Average Target
+5.86%
- Stock Market
- Certificates
- 9R81S Certificat
